AAM, PhRMA To Continue Battling Over Interchangeability Bill After Markup Delayed

By Jessica Karins / September 26, 2024 at 4:16 PM

The generic drug lobby plans to continue its push for passage of a bill opposed by brand drug makers that would automatically designate all biosimilar drugs as interchangeable with the reference products after a planned Thursday (Sept. 26) markup of the measure was postponed, the organization confirmed, with Congress’ lame duck period rapidly approaching.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.